معرفی
Steve Stayrook is an Associate Research Scientist in Pharmacology at Yale School of Medicine. His research focuses on structural biology of receptors, particularly receptor tyrosine kinases (RTKs) and their roles in cancer, development, and coagulation. Key areas include EGFR mutations in glioblastoma, ligand-receptor interactions in Drosophila, and engineered protein systems for synthetic biology applications.
Stayrook collaborates with prominent researchers like Mark Lemmon and Yuko Tsutsui, publishing in top journals such as Nature and Nature Communications. His work bridges structural biology with clinical relevance, addressing therapeutic targets for cancer and coagulation disorders. Notable contributions include elucidating EGFRvIII structural features and designing synthetic photosynthetic proteins.
His research themes span molecular oncology, protein engineering, and developmental signaling, with emphasis on structural mechanisms underlying disease and therapeutic intervention strategies.
